Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
American Journal of Respiratory and Critical Care Medicine|March 20, 2024
The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort StudyRajat Suri, Daniela Markovic, Han Woo, et al.
Chest|November 17, 2022
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPDSpyridon Fortis, Pedro M Quibrera, Alejandro P Comellas, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 3, 2022
Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS CohortBonnie E Ronish, David J Couper, Igor Z Barjaktarevic, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2026
TGFb signaling instructs a conserved fibrosis-associated cell state marked by LRRC15Justin A Shyer, Fabien Wehbe, Christopher D Davidson, et al.
Chest|February 4, 2021
Ratio of FEV<sub>1</sub>/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung FunctionSpyridon Fortis, Alejandro P Comellas, Surya P Bhatt, et al.
The New England Journal of Medicine|September 6, 2022
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung FunctionMeiLan K Han, Wen Ye, Di Wang, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort AnalysisIgor Z Barjaktarevic, Russell G Buhr, Xiaoyan Wang, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
JAMA|August 1, 2023
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved SpirometryWilliam McKleroy, Tracie Shing, Wayne H Anderson, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A <i>MUC5B</i> Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or MortalityAnurag Verma, Jessica Minnier, Emily S Wan, et al.
Pageof 8